Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Prospective, Open-label, one-way, fixed sequence drug-drug interaction study evaluating the effect of Rifampin or Itraconazole on the pharmacokinetics of Itacitinib in healthy volunteers

Trial Profile

A Prospective, Open-label, one-way, fixed sequence drug-drug interaction study evaluating the effect of Rifampin or Itraconazole on the pharmacokinetics of Itacitinib in healthy volunteers

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Sep 2018

At a glance

  • Drugs Itacitinib (Primary) ; Itraconazole; Rifampicin
  • Indications Graft-versus-host disease; Hodgkin's disease; Myelofibrosis; Non-Hodgkin's lymphoma; Non-small cell lung cancer; Solid tumours
  • Focus Pharmacokinetics
  • Most Recent Events

    • 28 Sep 2018 New trial record
    • 01 Sep 2018 Preliminary results published in the Clinical Pharmacology in Drug Development Conference: 2018 Annual Meeting of the American College of Clinical Pharmacology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top